Otsuka America Pharmaceutical

10 clinical trials · Sponsor

Record	Firm	Date
POCone-UBiT-IR300 Pediatric Comparison Study (NCT01623154)	Otsuka America Pharmaceutical	2012-07-01
Hyponatremia Registry for Patients With Euvolemic and Hypervolemic Hyponatremia (NCT01240668)	Otsuka America Pharmaceutical	2010-09-01
Study for the Treatment of Crohn's Disease With Adacolumn (NCT00162942)	Otsuka America Pharmaceutical	2005-01-01
Study for the Treatment of Ulcerative Colitis With Adacolumn (NCT00102193)	Otsuka America Pharmaceutical	2004-07-01
Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon (NCT00048776)	Otsuka America Pharmaceutical	2001-10-01
Safety and Efficacy of Pletal(Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud's Phenomenon (NCT00048763)	Otsuka America Pharmaceutical	2001-10-01
A Study of Multiple Doses of Vesnarinone in Advanced HIV Disease (NCT00002337)	Otsuka America Pharmaceutical
A Long-Term, Follow-On Safety Study of Four Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons (NCT00002130)	Otsuka America Pharmaceutical
A Phase I Study of Three Doses of OPC-8212 (Vesnarinone) in HIV-Infected Persons With CD4+ Cell Number > 300 Cells/mm3 (NCT00002129)	Otsuka America Pharmaceutical
A Pilot Study of OPC-8212 (Vesnarinone) in Persons With AIDS-Related Kaposi's Sarcoma (NCT00002131)	Otsuka America Pharmaceutical

Every clearance here is in the API, with alerts when new ones post.